Modal Container (Shows only in EE)
Modal ID: #cookie-management-modal
Open Modal
Close Modal

-

report

Medicines in Development 2022 Report: Disorders of the Blood

Young patient having his arm swabbed by a doctor

Today, there are more than 500 medicines in development for disorders of the blood. A new report from PhRMA explores these medicines that target these diseases and conditions.

Interested in reading more about Medicines in Development for Blood Disorders in 2022?

Get your free copy of the report now.

Related Resources

-

Read More

Researcher Profile: Justine Dell'Aringa

Justine Dell’Aringa is director of Translational Medicine at Bristol Myers Squibb (BMS) where she leads a team of researchers at the organization's Immuno-Oncology and Cell Therapy Thematic Research Center. 

Photo of Teresa (Teri) Foy, PhD, Senior Vice President of Research and Early Development, Immuno-Oncology and Cell Therapy at Bristol Myers Squibb

-

Read More

Researcher Profile: Teri Foy

Teri Foy, Ph.D, is the Senior Vice President of Research and Early Development. She oversees a team of researchers working tirelessly on translating scientific advances in immune effector cell-based therapies into treatments for hematological and solid cancers.

Teaser image of first page of PhRMA's Drug List for Medicines in Development for Blood Disorders 2022

-

read more

Medicines in Development for Blood Disorders 2022 Drug List

Dive deeper into the full list of medicines currently in development targeting disorders of the blood.

Teaser image for PhRMA's report on Gene Therapies 2022

-

Read More

Gene Therapies Can Bring Hope to Patients with Blood Disorders

Blood disorders often require lifelong treatment involving routine drug infusions or blood transfusions. They can also be associated with frequent visits to physician offices, infusion centers or even the emergency room.

The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry
Blog Post

Report: More than 500 medicines in development to treat disorders of the blood

Today, PhRMA released a new report covering 549 medicines in development to potentially treat disorders of the blood, including blood cancers.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.